CUMBERLAND, RI--(BUSINESS WIRE)-October 9, 2003-Collegium Pharmaceutical, Inc., a closely held specialty pharmaceutical company, today announced that it has relocated the Company's corporate headquarters to a new facility at Highland Corporate Park in Cumberland, Rhode Island. The site, which is approximately 25,000 square feet, incorporates all of Collegium's administrative functions as well as research and development including analytical laboratories and formulation development. The new facility represents a significant expansion from the Company's prior location in Hingham, Massachusetts and will allow the company to support its large number of on-going development projects and increasing staff.

"Collegium's move to its new facility reflects our commitment to supporting our rapidly expanding research and development activities. Over the past six months, we have added new staff who directly complement the growth of our specialty pharmaceutical projects. We are pleased to welcome Donald Tibbetts, PhD, as Vice President for Analytical Development," said Jessica Wolfe, PhD, Vice President for Administration, Collegium. Dr. Tibbetts was formerly Director of Quality Control at Copley Pharmaceutical. Prior to that, he held management and research positions at McNeil Consumer Products and Merck.

About Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc., is a privately held pharmaceutical company focused on the development of proprietary, late stage pharmaceutical products for the rapidly growing reformulation market and related areas. The Company's products target market opportunities through product improvement and line extension strategies protected by intellectual property (IP), creating a portfolio of improved pharmaceutical products. Collegium uses its broad expertise in IP development, drug formulation, manufacturing, basic science (chemistry, biology, bioengineering), marketing and clinical trials management to identify and execute product opportunities across multiple therapeutic areas. For more information, visit the Company's website at www.collegiumpharma.com.

Contacts:
Jessica Wolfe, Ph.D., MPH
Collegium Pharmaceutical
401-762-2000
jwolfe@collegiumpharma.com